Alnylam Sweden AB
559086-6686ActiveLeading RNAi therapeutics company developing gene-silencing medicines.
Översikt
- 5–9
- Anställda
- 100–500milj SEK
- Omsättning
- 2016
- Grundat
Nyckelbeslutsfattare
Jeff Poulton
Chief Financial Officer
Hiroshi Okada
President, Alnylam Japan
Bryan Supran
Chief Legal Officer
Pushkal Garg
Chief Research and Development Officer
+19 fler kontakter i Funnelfeedr
Beskrivning
Alnylam Pharmaceuticals is a leading global biopharmaceutical company dedicated to pioneering RNA interference (RNAi) therapeutics. They focus on developing an innovative class of medicines designed to treat diseases by silencing the specific genes responsible for causing them. This mechanism target...
Taggar
Nyckelord
Teknikstack
Företagsinformation
- Bransch
- Partihandel med medicinsk utrustning och apoteksvaror
- Juridisk form
- Aktiebolag
- Momsnummer
- SE559086668601
Beslutsfattare
23 kontakter i FunnelfeedrJeff Poulton
Chief Financial Officer
Hiroshi Okada
President, Alnylam Japan
Bryan Supran
Chief Legal Officer
Pushkal Garg
Chief Research and Development Officer
Stuart A. Arbuckle
Director
Peter N. Kellogg
Director
Tolga Tanguler
Chief Commercial Officer
Kevin Fitzgerald
Chief Scientific Officer
Margaret A. Hamburg
Director
Timothy Maines
Chief Technical Operations and Quality Officer
Elliott Sigal
Director
Yvonne Greenstreet
Chief Executive Officer
Dennis A. Ausiello
Director
Amy W. Schulman
Chair of the Board of Directors
Melissa McLaughlin
Chief Human Resources Officer
Olivier Brandicourt
Director
Colleen F. Reitan
Director
David E.I. Pyott
Director
Christine Akinc
Chief Corporate Communications Officer
Övriga kontakter
Jeffrey Vernon Poulton
Media Contact
Katarzyna Maria Witkos
Media Contact
Piyush Sharma
Chief Ethics & Compliance Officer
Carlos Pagnano
Media Contact
Liknande företag
20 liknande företag i FunnelfeedrAlexion Pharma Nordics AB
10–19 anställdaPioneering transformative medicines for the global rare disease community.
Purpose Pharma International AB
5–9 anställdaDeveloping and supplying rare disease treatments across Europe.
PTC Therapeutics Sweden AB
Developing transformative treatments for rare diseases globally for patients.
ASTRAZENECA PLC
1–4 anställdaGlobal science-led pharmaceutical business developing life-changing medicines.
ScandiBio Therapeutics AB
0 anställdaAI-driven biotechnology company developing drugs targeting mitochondrial dysfunction.
Utforska mer
Frågor om Alnylam Sweden AB
Vill du se Funnelfeedr i praktiken?
Boka en gratis demo och upptäck hur Funnelfeedr hjälper dig att hitta och konvertera dina idealkunder.
Boka en demo